The global Retinal Disorder Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. This report aims to provide a comprehensive presentation of the global market for Retinal Disorder Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Retinal Disorder Drug. This report contains market size and forecasts of Retinal Disorder Drug in global, including the following market information:
Global Retinal Disorder Drug Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Glaucoma Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Retinal Disorder Drug include Novartis Allergan, Roche, Valeant, Regeneron, Alcon inc., Pfizer inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd. and Bausch and Lomb Incorporated, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Retinal Disorder Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Retinal Disorder Drug Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Retinal Disorder Drug Market Segment Percentages, by Type, 2022 (%)
- Glaucoma
- Dry Eye Syndrome
Global Retinal Disorder Drug Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Retinal Disorder Drug Market Segment Percentages, by Application, 2022 (%)
- Hospital Pharmacy
- Drugs Store
- Online Pharmacies
Global Retinal Disorder Drug Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Retinal Disorder Drug Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Retinal Disorder Drug revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Retinal Disorder Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Novartis Allergan
- Roche
- Valeant
- Regeneron
- Alcon inc.
- Pfizer inc.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Bausch and Lomb Incorporated
Outline of Major Chapters:
Chapter 1: Introduces the definition of Retinal Disorder Drug, market overview.
Chapter 2: Global Retinal Disorder Drug market size in revenue.
Chapter 3: Detailed analysis of Retinal Disorder Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Retinal Disorder Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Retinal Disorder Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Retinal Disorder Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Retinal Disorder Drug Overall Market Size
2.1 Global Retinal Disorder Drug Market Size: 2022 VS 2030
2.2 Global Retinal Disorder Drug Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Retinal Disorder Drug Players in Global Market
3.2 Top Global Retinal Disorder Drug Companies Ranked by Revenue
3.3 Global Retinal Disorder Drug Revenue by Companies
3.4 Top 3 and Top 5 Retinal Disorder Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Retinal Disorder Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Retinal Disorder Drug Players in Global Market
3.6.1 List of Global Tier 1 Retinal Disorder Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Retinal Disorder Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Retinal Disorder Drug Market Size Markets, 2022 & 2030
4.1.2 Glaucoma
4.1.3 Dry Eye Syndrome
4.2 By Type - Global Retinal Disorder Drug Revenue & Forecasts
4.2.1 By Type - Global Retinal Disorder Drug Revenue, 2018-2023
4.2.2 By Type - Global Retinal Disorder Drug Revenue, 2024-2030
4.2.3 By Type - Global Retinal Disorder Drug Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Retinal Disorder Drug Market Size, 2022 & 2030
5.1.2 Hospital Pharmacy
5.1.3 Drugs Store
5.1.4 Online Pharmacies
5.2 By Application - Global Retinal Disorder Drug Revenue & Forecasts
5.2.1 By Application - Global Retinal Disorder Drug Revenue, 2018-2023
5.2.2 By Application - Global Retinal Disorder Drug Revenue, 2024-2030
5.2.3 By Application - Global Retinal Disorder Drug Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Retinal Disorder Drug Market Size, 2022 & 2030
6.2 By Region - Global Retinal Disorder Drug Revenue & Forecasts
6.2.1 By Region - Global Retinal Disorder Drug Revenue, 2018-2023
6.2.2 By Region - Global Retinal Disorder Drug Revenue, 2024-2030
6.2.3 By Region - Global Retinal Disorder Drug Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Retinal Disorder Drug Revenue, 2018-2030
6.3.2 US Retinal Disorder Drug Market Size, 2018-2030
6.3.3 Canada Retinal Disorder Drug Market Size, 2018-2030
6.3.4 Mexico Retinal Disorder Drug Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Retinal Disorder Drug Revenue, 2018-2030
6.4.2 Germany Retinal Disorder Drug Market Size, 2018-2030
6.4.3 France Retinal Disorder Drug Market Size, 2018-2030
6.4.4 U.K. Retinal Disorder Drug Market Size, 2018-2030
6.4.5 Italy Retinal Disorder Drug Market Size, 2018-2030
6.4.6 Russia Retinal Disorder Drug Market Size, 2018-2030
6.4.7 Nordic Countries Retinal Disorder Drug Market Size, 2018-2030
6.4.8 Benelux Retinal Disorder Drug Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Retinal Disorder Drug Revenue, 2018-2030
6.5.2 China Retinal Disorder Drug Market Size, 2018-2030
6.5.3 Japan Retinal Disorder Drug Market Size, 2018-2030
6.5.4 South Korea Retinal Disorder Drug Market Size, 2018-2030
6.5.5 Southeast Asia Retinal Disorder Drug Market Size, 2018-2030
6.5.6 India Retinal Disorder Drug Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Retinal Disorder Drug Revenue, 2018-2030
6.6.2 Brazil Retinal Disorder Drug Market Size, 2018-2030
6.6.3 Argentina Retinal Disorder Drug Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Retinal Disorder Drug Revenue, 2018-2030
6.7.2 Turkey Retinal Disorder Drug Market Size, 2018-2030
6.7.3 Israel Retinal Disorder Drug Market Size, 2018-2030
6.7.4 Saudi Arabia Retinal Disorder Drug Market Size, 2018-2030
6.7.5 UAE Retinal Disorder Drug Market Size, 2018-2030
7 Retinal Disorder Drug Companies Profiles
7.1 Novartis Allergan
7.1.1 Novartis Allergan Company Summary
7.1.2 Novartis Allergan Business Overview
7.1.3 Novartis Allergan Retinal Disorder Drug Major Product Offerings
7.1.4 Novartis Allergan Retinal Disorder Drug Revenue in Global Market (2018-2023)
7.1.5 Novartis Allergan Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche Retinal Disorder Drug Major Product Offerings
7.2.4 Roche Retinal Disorder Drug Revenue in Global Market (2018-2023)
7.2.5 Roche Key News & Latest Developments
7.3 Valeant
7.3.1 Valeant Company Summary
7.3.2 Valeant Business Overview
7.3.3 Valeant Retinal Disorder Drug Major Product Offerings
7.3.4 Valeant Retinal Disorder Drug Revenue in Global Market (2018-2023)
7.3.5 Valeant Key News & Latest Developments
7.4 Regeneron
7.4.1 Regeneron Company Summary
7.4.2 Regeneron Business Overview
7.4.3 Regeneron Retinal Disorder Drug Major Product Offerings
7.4.4 Regeneron Retinal Disorder Drug Revenue in Global Market (2018-2023)
7.4.5 Regeneron Key News & Latest Developments
7.5 Alcon inc.
7.5.1 Alcon inc. Company Summary
7.5.2 Alcon inc. Business Overview
7.5.3 Alcon inc. Retinal Disorder Drug Major Product Offerings
7.5.4 Alcon inc. Retinal Disorder Drug Revenue in Global Market (2018-2023)
7.5.5 Alcon inc. Key News & Latest Developments
7.6 Pfizer inc.
7.6.1 Pfizer inc. Company Summary
7.6.2 Pfizer inc. Business Overview
7.6.3 Pfizer inc. Retinal Disorder Drug Major Product Offerings
7.6.4 Pfizer inc. Retinal Disorder Drug Revenue in Global Market (2018-2023)
7.6.5 Pfizer inc. Key News & Latest Developments
7.7 Sun Pharmaceutical Industries Ltd.
7.7.1 Sun Pharmaceutical Industries Ltd. Company Summary
7.7.2 Sun Pharmaceutical Industries Ltd. Business Overview
7.7.3 Sun Pharmaceutical Industries Ltd. Retinal Disorder Drug Major Product Offerings
7.7.4 Sun Pharmaceutical Industries Ltd. Retinal Disorder Drug Revenue in Global Market (2018-2023)
7.7.5 Sun Pharmaceutical Industries Ltd. Key News & Latest Developments
7.8 Teva Pharmaceutical Industries Ltd.
7.8.1 Teva Pharmaceutical Industries Ltd. Company Summary
7.8.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.8.3 Teva Pharmaceutical Industries Ltd. Retinal Disorder Drug Major Product Offerings
7.8.4 Teva Pharmaceutical Industries Ltd. Retinal Disorder Drug Revenue in Global Market (2018-2023)
7.8.5 Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
7.9 Bausch and Lomb Incorporated
7.9.1 Bausch and Lomb Incorporated Company Summary
7.9.2 Bausch and Lomb Incorporated Business Overview
7.9.3 Bausch and Lomb Incorporated Retinal Disorder Drug Major Product Offerings
7.9.4 Bausch and Lomb Incorporated Retinal Disorder Drug Revenue in Global Market (2018-2023)
7.9.5 Bausch and Lomb Incorporated Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Retinal Disorder Drug Market Opportunities & Trends in Global Market
Table 2. Retinal Disorder Drug Market Drivers in Global Market
Table 3. Retinal Disorder Drug Market Restraints in Global Market
Table 4. Key Players of Retinal Disorder Drug in Global Market
Table 5. Top Retinal Disorder Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Retinal Disorder Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Retinal Disorder Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Retinal Disorder Drug Product Type
Table 9. List of Global Tier 1 Retinal Disorder Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Retinal Disorder Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Retinal Disorder Drug Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Retinal Disorder Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Retinal Disorder Drug Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Retinal Disorder Drug Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Retinal Disorder Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Retinal Disorder Drug Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Retinal Disorder Drug Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Retinal Disorder Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Retinal Disorder Drug Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Retinal Disorder Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Retinal Disorder Drug Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Retinal Disorder Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Retinal Disorder Drug Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Retinal Disorder Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Retinal Disorder Drug Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Retinal Disorder Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Retinal Disorder Drug Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Retinal Disorder Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Retinal Disorder Drug Revenue, (US$, Mn), 2024-2030
Table 30. Novartis Allergan Company Summary
Table 31. Novartis Allergan Retinal Disorder Drug Product Offerings
Table 32. Novartis Allergan Retinal Disorder Drug Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis Allergan Key News & Latest Developments
Table 34. Roche Company Summary
Table 35. Roche Retinal Disorder Drug Product Offerings
Table 36. Roche Retinal Disorder Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Roche Key News & Latest Developments
Table 38. Valeant Company Summary
Table 39. Valeant Retinal Disorder Drug Product Offerings
Table 40. Valeant Retinal Disorder Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Valeant Key News & Latest Developments
Table 42. Regeneron Company Summary
Table 43. Regeneron Retinal Disorder Drug Product Offerings
Table 44. Regeneron Retinal Disorder Drug Revenue (US$, Mn) & (2018-2023)
Table 45. Regeneron Key News & Latest Developments
Table 46. Alcon inc. Company Summary
Table 47. Alcon inc. Retinal Disorder Drug Product Offerings
Table 48. Alcon inc. Retinal Disorder Drug Revenue (US$, Mn) & (2018-2023)
Table 49. Alcon inc. Key News & Latest Developments
Table 50. Pfizer inc. Company Summary
Table 51. Pfizer inc. Retinal Disorder Drug Product Offerings
Table 52. Pfizer inc. Retinal Disorder Drug Revenue (US$, Mn) & (2018-2023)
Table 53. Pfizer inc. Key News & Latest Developments
Table 54. Sun Pharmaceutical Industries Ltd. Company Summary
Table 55. Sun Pharmaceutical Industries Ltd. Retinal Disorder Drug Product Offerings
Table 56. Sun Pharmaceutical Industries Ltd. Retinal Disorder Drug Revenue (US$, Mn) & (2018-2023)
Table 57. Sun Pharmaceutical Industries Ltd. Key News & Latest Developments
Table 58. Teva Pharmaceutical Industries Ltd. Company Summary
Table 59. Teva Pharmaceutical Industries Ltd. Retinal Disorder Drug Product Offerings
Table 60. Teva Pharmaceutical Industries Ltd. Retinal Disorder Drug Revenue (US$, Mn) & (2018-2023)
Table 61. Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
Table 62. Bausch and Lomb Incorporated Company Summary
Table 63. Bausch and Lomb Incorporated Retinal Disorder Drug Product Offerings
Table 64. Bausch and Lomb Incorporated Retinal Disorder Drug Revenue (US$, Mn) & (2018-2023)
Table 65. Bausch and Lomb Incorporated Key News & Latest Developments
List of Figures
Figure 1. Retinal Disorder Drug Segment by Type in 2022
Figure 2. Retinal Disorder Drug Segment by Application in 2022
Figure 3. Global Retinal Disorder Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Retinal Disorder Drug Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Retinal Disorder Drug Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Retinal Disorder Drug Revenue in 2022
Figure 8. By Type - Global Retinal Disorder Drug Revenue Market Share, 2018-2030
Figure 9. By Application - Global Retinal Disorder Drug Revenue Market Share, 2018-2030
Figure 10. By Type - Global Retinal Disorder Drug Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Retinal Disorder Drug Revenue Market Share, 2018-2030
Figure 12. By Application - Global Retinal Disorder Drug Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Retinal Disorder Drug Revenue Market Share, 2018-2030
Figure 14. By Region - Global Retinal Disorder Drug Revenue Market Share, 2018-2030
Figure 15. By Country - North America Retinal Disorder Drug Revenue Market Share, 2018-2030
Figure 16. US Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Retinal Disorder Drug Revenue Market Share, 2018-2030
Figure 20. Germany Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 21. France Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Retinal Disorder Drug Revenue Market Share, 2018-2030
Figure 28. China Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 32. India Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Retinal Disorder Drug Revenue Market Share, 2018-2030
Figure 34. Brazil Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Retinal Disorder Drug Revenue Market Share, 2018-2030
Figure 37. Turkey Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 41. Novartis Allergan Retinal Disorder Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Roche Retinal Disorder Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Valeant Retinal Disorder Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Regeneron Retinal Disorder Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Alcon inc. Retinal Disorder Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Pfizer inc. Retinal Disorder Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Sun Pharmaceutical Industries Ltd. Retinal Disorder Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Teva Pharmaceutical Industries Ltd. Retinal Disorder Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bausch and Lomb Incorporated Retinal Disorder Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
